Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levent Verim

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Asian Pacific Journal of Cancer Prevention : APJCP|December 3, 2013
Impact of PSA and DRE on histologic findings at prostate biopsy in Turkish men over 75 years of ageLevent Verim, Asif Yildirim, Erem Kaan Basok, et al.
In Vivo (Athens, Greece)|June 29, 2011
The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish populationTülin Öztürk, Özlem Timirci Kahraman, Bahar Toptaş, et al.
Urologic Oncology|December 9, 2025
Evaluation of kynurenine and tryptophan metabolism in bladder cancer: Diagnostic and prognostic implications of IDO1 polymorphismKemal Kayar, Rıdvan Kayar, Dilara Sönmez, et al.
In Vivo (Athens, Greece)|May 13, 2014
Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish populationLevent Verim, Ozlem Timirci-Kahraman, Habib Akbulut, et al.
Archivos Espanoles De Urologia|April 7, 2026
Distribution of PD-1.5 Gene Variant (rs2227981): A Possible Approach for Risk Assessment in Bladder CancerKemal Kayar, Levent Verim, Dilara Sonmez, et al.
Genetic Testing and Molecular Biomarkers|May 9, 2015
Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancerOzlem Timirci-Kahraman, Nazli Ezgi Ozkan, Saime Turan, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Asian Pacific Journal of Cancer Prevention : APJCP|December 3, 2013
Impact of PSA and DRE on histologic findings at prostate biopsy in Turkish men over 75 years of ageLevent Verim, Asif Yildirim, Erem Kaan Basok, et al.
In Vivo (Athens, Greece)|June 29, 2011
The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish populationTülin Öztürk, Özlem Timirci Kahraman, Bahar Toptaş, et al.
Urologic Oncology|December 9, 2025
Evaluation of kynurenine and tryptophan metabolism in bladder cancer: Diagnostic and prognostic implications of IDO1 polymorphismKemal Kayar, Rıdvan Kayar, Dilara Sönmez, et al.
In Vivo (Athens, Greece)|May 13, 2014
Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish populationLevent Verim, Ozlem Timirci-Kahraman, Habib Akbulut, et al.
Archivos Espanoles De Urologia|April 7, 2026
Distribution of PD-1.5 Gene Variant (rs2227981): A Possible Approach for Risk Assessment in Bladder CancerKemal Kayar, Levent Verim, Dilara Sonmez, et al.
Genetic Testing and Molecular Biomarkers|May 9, 2015
Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancerOzlem Timirci-Kahraman, Nazli Ezgi Ozkan, Saime Turan, et al.
Pageof 2